UPDATE: Jefferies Raises PT on HealthSouth to $30 (HLS)

Jefferies is out with its report today on HealthSouth HLS, raising its PT to $30. In a note to clients, Jefferies writes, "HLS continues to deliver impressive earnings results driven by robust discharge growth and tight cost control. With HLS's guidance seemingly conservative (even before potential savings from the planned call of $285MM worth of 10.75% senior notes in June), the stock has compelling upside, in our view. Reiterate Buy/$30 PT (raised from $28)." Shares of HLS closed Thursday at $24.72.